Michael F Berger

Department of Pathology, Memorial Sloan-Kettering Cancer Center

Affiliated withMemorial Sloan-Kettering Cancer Center

Research Area

Biography

Michael F Berger has not added Biography.
If you are Michael F Berger and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 64	2013

Other Publications

Article	Year
Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays. Nature genetics\| PubMed ID: 15543148	2004
Protein binding microarrays (PBMs) for rapid, high-throughput characterization of the sequence specificities of DNA binding proteins. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 16888363	2006
Compact, universal DNA microarrays to comprehensively determine transcription-factor binding site specificities. Nature biotechnology\| PubMed ID: 16998473	2006
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Genome research\| PubMed ID: 17322287	2007
Inferring condition-specific transcription factor function from DNA binding and gene expression data. Molecular systems biology\| PubMed ID: 17437025	2007
Microarray analyses of newborn mouse ovaries lacking Nobox. Biology of reproduction\| PubMed ID: 17494914	2007
Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell\| PubMed ID: 18585359	2008
Design of compact, universal DNA microarrays for protein binding microarray experiments. Journal of computational biology : a journal of computational molecular cell biology\| PubMed ID: 18651798	2008
The Vibrio harveyi master quorum-sensing regulator, LuxR, a TetR-type protein is both an activator and a repressor: DNA recognition and binding specificity at target promoters. Molecular microbiology\| PubMed ID: 18681939	2008
Predicting the binding preference of transcription factors to individual DNA k-mers. Bioinformatics (Oxford, England)\| PubMed ID: 19088121	2009
Genome-wide promoter analysis of the SOX4 transcriptional network in prostate cancer cells. Cancer research\| PubMed ID: 19147588	2009
High-resolution DNA-binding specificity analysis of yeast transcription factors. Genome research\| PubMed ID: 19158363	2009
Universal protein-binding microarrays for the comprehensive characterization of the DNA-binding specificities of transcription factors. Nature protocols\| PubMed ID: 19265799	2009
Diversity and complexity in DNA recognition by transcription factors. Science (New York, N.Y.)\| PubMed ID: 19443739	2009
Applications of genomics in melanoma oncogene discovery. Hematology/oncology clinics of North America\| PubMed ID: 19464593	2009
Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts. Genome biology\| PubMed ID: 19835606	2009
Conservation and regulatory associations of a wide affinity range of mouse transcription factor binding sites. Genomics\| PubMed ID: 20079828	2010
Integrative analysis of the melanoma transcriptome. Genome research\| PubMed ID: 20179022	2010
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo. The EMBO journal\| PubMed ID: 20517297	2010
Objective sequence-based subfamily classifications of mouse homeodomains reflect their in vitro DNA-binding preferences. Nucleic acids research\| PubMed ID: 20705649	2010
Notch and MAML-1 complexation do not detectably alter the DNA binding specificity of the transcription factor CSL. PloS one\| PubMed ID: 21124806	2010
The genomic complexity of primary human prostate cancer. Nature\| PubMed ID: 21307934	2011
Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21383288	2011
The mutational landscape of head and neck squamous cell carcinoma. Science (New York, N.Y.)\| PubMed ID: 21798893	2011
Molecular mechanism underlying the regulatory specificity of a Drosophila homeodomain protein that specifies myoblast identity. Development (Cambridge, England)\| PubMed ID: 22296846	2012
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature\| PubMed ID: 22460905	2012
High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. Cancer discovery\| PubMed ID: 22585170	2012
Melanoma genome sequencing reveals frequent PREX2 mutations. Nature\| PubMed ID: 22622578	2012
Genome sequencing identifies a basis for everolimus sensitivity. Science (New York, N.Y.)\| PubMed ID: 22923433	2012
BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer. Cancer\| PubMed ID: 22930283	2013
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23444215	2013
Punctuated evolution of prostate cancer genomes. Cell\| PubMed ID: 23622249	2013